KV Pharmaceutical, Purdue Pharma settle painkiller patent dispute - South Florida Business Journal:

humojo.wordpress.com
Under the settlement, KV agreed to no longer disputerthe “validity, enforceability or infringement” of the Purdue genericc oxycodone patents. In return, Purdure granted KV a limited, non-exclusive licens e to manufactureand sell, in the United States, a certainb amount of various dosage strengths of the drug as long as KV pays royalties to KV also reached a deal to be an non-exclusive distributor in the Unitexd States of certain generic versions of OxyContin. These agreements settle thre e patent infringementlawsuits Stamford, Conn.-based Purdue filed against KV in 2007. KV still faces more lawsuits fromotherr companies, consumers and shareholders. Three individuals in St.
Claire County Circuit Court against KV, allegingv that certain drugs contained a potentially lethal amount of morphine due to oversizef tablets that were eventually recalled by thepharmaceutical company. Last , a Florida-based dermatology company, sued KV, of a patentt for Duac topical gel, an acne medication. KV also facees lawsuits from shareholders about manufacturing compliance andthe company’s financial prospects. Brentwood, Mo.-based KV has and recalled painkillers. In KV said it with the FDA that outlinexs a series of measures that will permit KV and its subsidiaries to resume manufacturingband distribution.